Table 2.

Tumor response to tivantinib in Phase 1B trial^a

Tumor response	Complete response	Partial response	Stable disease
Patients, n (%)	0	0	9 (56)

Notes:

^aOnly 16 of 21 patients were able to be evaluated for tumor response. Data from Santoro et al.⁴²